✨ Free AI Report
Genscript Biotech: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Genscript Biotech
Company Research

Genscript Biotech: Business Overview, Financials & Competitive Analysis

Genscript Biotech scores 7/10 on the AskCyborg Cyborg Score (Strong). Well-positioned synthetic biology and life sciences platform with expanding CAR-T pipeline and global reach, though geopolitical risks require monitoring. Genscript demonstrates strong fundamentals with diversified revenue streams, significant analyst coverage showing buy ratings, and strategic expansion. However, geopolitical scrutiny and net losses from subsidiary Legend Biotech temper upside momentum. Analyst.

What is Genscript Biotech's industry? Genscript Biotech (genscript.com) operates in Synthetic Biology / Life Sciences Research and Therapeutics. AskCyborg classifies Genscript Biotech under Synthetic Biology / Life Sciences Research and Therapeutics in its company registry.

Genscript Biotech is an investment holding company that manufactures and sells life science research products and services globally through three segments: Life Science Services and Products; Biologics Development Ser...

7/ 10Strong

Cyborg Score thesis

Well-positioned synthetic biology and life sciences platform with expanding CAR-T pipeline and global reach, though geopolitical...

Read the full analyst-debate transcript →
Industry Synthetic Biology / Life Sciences Research and Therapeutics
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: September 14, 2026
AI-Verified Research
30+ Page Report

Get the Latest Genscript Biotech Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for Genscript Biotech

AskCyborg analysts argue the bull and bear cases for Genscript Biotech across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Genscript Biotech OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

Genscript Biotech Overview

Pro stress-test →

Genscript Biotech is an investment holding company that manufactures and sells life science research products and services globally through three segments: Life Science Services and Products; Biologics Development Services; and Industrial Synthetic Biology Products. The company is positioning itself for increased market share and margin improvement in the life sciences sector through investments in automation, proprietary technology, and global expansion.

Strategic Profile

Pro stress-test →

Innovative product launches and expanded regulatory compliance are supporting revenue diversification, pricing power, and long-term growth outside the China market. Recent earnings highlights showed significant revenue growth across all segments and strong performance of Legend Biotech's CAR-T product with a robust cash position.

Competitive Landscape

Pro stress-test →

Genscript competes in synthetic biology and life sciences against companies like Twist Bioscience (TWST). The company differentiates through its integrated platform spanning gene synthesis, protein engineering, CAR-T development via Legend Biotech subsidiary, and industrial enzymes. Its market position strengthens through strategic partnerships including collaborations with Janssen and Novartis on CAR-T therapies.

Industry Context

Genscript Biotech operates in Synthetic Biology / Life Sciences Research and Therapeutics.

Key facts

Founded: 2002 · Headquarters: Nanjing, China

What the analysts stress-tested

The top findings that survived the multi-agent debate for Genscript Biotech.

  • Core business across three segments generates diversified revenue with exposure to research, therapeutic development, and industrial biotech applications
  • Legend Biotech CAR-T program showing strong momentum with FDA approvals and major partnerships including Janssen and Novartis collaborations
+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • November 2023Legend Biotech signed major out-license deal with Novartis for CAR-T therapies with potential for $1.01 billion in milestone payments
  • May 2024US House Select Committee requested FBI briefing on potential Chinese government influence over Genscript and subsidiaries
  • +1 moreTrack every material event for Genscript Biotech as it happens. Explore monitoring →
Get alerted when Genscript Biotech has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Twist BioscienceSynthetic DNA manufacturing and biotech tools→Legend Biotech (subsidiary)CAR-T cell therapy development and manufacturing→Bestzyme (subsidiary)Industrial enzyme production and synthetic biology→

Compare Genscript Biotech with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Genscript Biotech operates in Synthetic Biology / Life Sciences Research and Therapeutics. See how the rest of the sector scores on the Cyborg framework.

Browse Synthetic Biology / Life Sciences Research and Therapeutics research →
NEW · MCP server

Ask your AI assistant about Genscript Biotech

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Genscript Biotech and its top competitor on Cyborg Score”
“What did Genscript Biotech do this quarter?”
“Is Genscript Biotech a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Genscript Biotech do?+
Genscript Biotech is an investment holding company that manufactures and sells life science research products and services globally through three segments: Life Science Services and Products; Biologics Development Ser...
What is Genscript Biotech's Cyborg Score?+
Genscript Biotech has a Cyborg Score of 7/10 (Strong). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Genscript Biotech's main competitors?+
Named competitors include Twist Bioscience, Legend Biotech (subsidiary), Bestzyme (subsidiary). The full competitive landscape is in the AskCyborg report.
How can I get the full Genscript Biotech research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Genscript Biotech research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Genscript Biotech over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More Synthetic Biology research

Companies in the same sector and named competitors, ranked by Cyborg Score.

74basebio PLC7Twist Bioscience Corporation4Ginkgo Bioworks Holdings, Inc.